0.8 |
3.1 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
0.4 |
2.0 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
0.3 |
1.4 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
0.3 |
1.0 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.3 |
2.0 |
GO:0036233 |
glycine import(GO:0036233) |
0.3 |
1.5 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
0.3 |
0.9 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
0.3 |
1.8 |
GO:0002934 |
desmosome organization(GO:0002934) |
0.3 |
1.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
0.2 |
1.0 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
0.2 |
2.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 |
0.7 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.2 |
1.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
0.2 |
0.6 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
0.2 |
0.6 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 |
0.6 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) glutamate secretion, neurotransmission(GO:0061535) |
0.2 |
1.2 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 |
0.5 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 |
1.4 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
0.1 |
0.1 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
0.1 |
0.4 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 |
1.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
0.1 |
1.0 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
0.1 |
0.5 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
0.1 |
0.5 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 |
1.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 |
0.5 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
0.1 |
0.4 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 |
0.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
0.1 |
0.4 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 |
0.5 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
0.1 |
0.3 |
GO:0003032 |
detection of oxygen(GO:0003032) |
0.1 |
0.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 |
0.9 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 |
0.2 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 |
0.3 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 |
0.6 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 |
0.3 |
GO:0070103 |
interleukin-4-mediated signaling pathway(GO:0035771) tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.1 |
0.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 |
0.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
0.1 |
0.4 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 |
0.3 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
0.1 |
0.2 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 |
0.4 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 |
0.6 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
0.1 |
1.6 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
0.1 |
0.4 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 |
0.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
0.1 |
1.4 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 |
0.3 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.1 |
0.9 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 |
0.7 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 |
1.4 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 |
0.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.1 |
0.3 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 |
0.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) resolution of recombination intermediates(GO:0071139) |
0.1 |
0.2 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
0.1 |
0.6 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 |
0.2 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.1 |
0.4 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
0.1 |
0.5 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 |
0.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
0.1 |
0.3 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
0.1 |
0.2 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
0.1 |
0.3 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 |
0.6 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 |
0.2 |
GO:0003192 |
mitral valve formation(GO:0003192) |
0.1 |
0.5 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 |
1.3 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
0.0 |
0.4 |
GO:0051608 |
histamine transport(GO:0051608) |
0.0 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
0.0 |
0.9 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 |
0.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 |
1.3 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
0.0 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
0.0 |
0.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
0.0 |
0.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
0.0 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 |
0.4 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 |
1.9 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
0.0 |
0.4 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
0.0 |
0.2 |
GO:0090292 |
nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 |
0.3 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
0.0 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 |
0.2 |
GO:0048859 |
negative regulation of epidermal cell differentiation(GO:0045605) formation of anatomical boundary(GO:0048859) |
0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
0.0 |
1.1 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
0.0 |
0.5 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
0.0 |
0.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 |
0.4 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 |
0.6 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
0.0 |
0.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
0.0 |
0.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 |
0.1 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
0.0 |
0.1 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.0 |
0.1 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
0.0 |
0.3 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 |
0.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 |
0.6 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 |
0.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
0.0 |
0.7 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 |
0.4 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
0.0 |
0.4 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
0.0 |
0.1 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
0.0 |
0.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 |
0.1 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 |
0.5 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
0.0 |
0.3 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 |
0.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
0.0 |
0.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
0.0 |
0.3 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 |
0.1 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
0.0 |
0.1 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.0 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
0.0 |
0.4 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 |
0.2 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
0.0 |
0.3 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 |
0.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
0.0 |
0.0 |
GO:0097402 |
neuroblast migration(GO:0097402) |
0.0 |
0.0 |
GO:0097107 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.0 |
0.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
0.0 |
0.1 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
0.0 |
0.0 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
0.0 |
0.3 |
GO:0030431 |
sleep(GO:0030431) |
0.0 |
1.4 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 |
0.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 |
0.0 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
0.0 |
0.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
0.0 |
0.3 |
GO:0030488 |
tRNA methylation(GO:0030488) |